Multispectral Optoacoustic Tomography Noninvasively Reveals Ultrastructural Muscle Changes and Associates With Clinical Disability in Inclusion Body Myositis

Inclusion body myositis (IBM), the most common idiopathic inflammatory myopathy in older adults, causes progressive disability, dysphagia, and respiratory complications. Sensitive, objective and repeatable imaging biomarkers for diagnosis, staging and monitoring remain unavailable, and diagnosis continues to rely on muscle biopsy. The aim of this study was to determine whether multispectral optoacoustic tomography (MSOT) detects disease‐relevant alterations in skeletal muscle composition and provides quantitative markers of clinical impairment in IBM. Extremity muscles were examined using MSOT in 10 IBM patients and 10 age‐ and sex‐matched healthy volunteers. MSOT‐derived markers for intramuscular lipid (MSOT_LIP), collagen (MSOT_COL), deoxygenated (MSOT_Hb), and oxygenated hemoglobin (MSOT_HbO 2 ) signals were quantified and associated with muscle strength, mobility, and the IBM‐functional rating scale (IBM‐FRS). MSOT_LIP was significantly increased in IBM, particularly in leg muscles, whereas MSOT_COL was significantly reduced. Higher MSOT_LIP was associated with lower muscle strength and impaired mobility, and increased MSOT_LIP and decreased MSOT_COL were both associated with greater impairment measured by clinical assessment (IBM‐FRS and functional disability index (FDI)). MSOT noninvasively identifies disease‐relevant changes in skeletal muscle tissue composition. These quantitative readouts may complement current assessments and provide objective biomarkers for disease staging, longitudinal monitoring, and evaluation of therapeutic responses in future clinical trials. Trial Registration : The study was registered retrospectively at the German clinical trial registry (DRKS) under the registration number DRKS00033110 at 29.11.2023.

Authors

Institutions

Publication Details

Journal
MedComm
Published
2026-11-18
DOI
https://doi.org/10.1002/mco2.71152
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multispectral Optoacoustic Tomography Noninvasively Reveals Ultrastructural Muscle Changes and Associates With Clinical Disability in Inclusion Body Myositis

Mathias Bähr, Stefanie Meyer, Frauke Alves, Ferdinand Knieling et al.
MedComm
Inflammatory Myopathies and Dermatomyositis
article

Multispectral Optoacoustic Tomography Noninvasively Reveals Ultrastructural Muscle Changes and Associates With Clinical Disability in Inclusion Body Myositis

Mathias Bähr, Stefanie Meyer, Frauke Alves, Ferdinand Knieling, Stephan von Haehling, Roman Raming, Stefanie Glaubitz, Janek Gröhl, Jana Zschüntzsch, Alica Stobbe, Hannah Bruex, Dörthe Malzahn
article en

Abstract

Inclusion body myositis (IBM), the most common idiopathic inflammatory myopathy in older adults, causes progressive disability, dysphagia, and respiratory complications. Sensitive, objective and repeatable imaging biomarkers for diagnosis, staging and monitoring remain unavailable, and diagnosis continues to rely on muscle biopsy. The aim of this study was to determine whether multispectral optoacoustic tomography (MSOT) detects disease‐relevant alterations in skeletal muscle composition and provides quantitative markers of clinical impairment in IBM. Extremity muscles were examined using MSOT in 10 IBM patients and 10 age‐ and sex‐matched healthy volunteers. MSOT‐derived markers for intramuscular lipid (MSOT_LIP), collagen (MSOT_COL), deoxygenated (MSOT_Hb), and oxygenated hemoglobin (MSOT_HbO 2 ) signals were quantified and associated with muscle strength, mobility, and the IBM‐functional rating scale (IBM‐FRS). MSOT_LIP was significantly increased in IBM, particularly in leg muscles, whereas MSOT_COL was significantly reduced. Higher MSOT_LIP was associated with lower muscle strength and impaired mobility, and increased MSOT_LIP and decreased MSOT_COL were both associated with greater impairment measured by clinical assessment (IBM‐FRS and functional disability index (FDI)). MSOT noninvasively identifies disease‐relevant changes in skeletal muscle tissue composition. These quantitative readouts may complement current assessments and provide objective biomarkers for disease staging, longitudinal monitoring, and evaluation of therapeutic responses in future clinical trials. Trial Registration : The study was registered retrospectively at the German clinical trial registry (DRKS) under the registration number DRKS00033110 at 29.11.2023.

MedCommVol. 7(12)
Max Planck Society (DE), Universitätsklinikum Erlangen (DE), Universitätsmedizin Göttingen (DE), Universitätsklinikum Aachen (DE), Max Planck Institute for Multidisciplinary Sciences (DE), University of Göttingen (DE), RWTH Aachen University (DE)
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon